Differential expression of prostaglandin h synthase isozymes during multistage carcinogenesis in mouse epidermis

Molecular Carcinogenesis

Volumn 12, Issue 1, 1995, Pages 31-41

  Müller‐Decker, Karin ^a   Scholz, Kirsten ^a   Marks, Friedrich ^a   Fürstenberger, Gerhard ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Multistage skin carcinogenesis in mouse; nonsteroidal anti inflammatory drug; prostaglandin H synthase isozymes

Indexed keywords

DIMETHYLBENZ[A]ANTHRACENE; INDOMETACIN; ISOENZYME; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EPIDERMIS; FEMALE; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CARCINOGENESIS;

AMINO ACID SEQUENCE; ANIMAL; CARCINOMA; CELL TRANSFORMATION, NEOPLASTIC; COCARCINOGENESIS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; ISOENZYMES; KERATINOCYTES; MICE; MOLECULAR SEQUENCE DATA; PAPILLOMA; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE; SKIN NEOPLASMS; SUPPORT, NON-U.S. GOV'T; TETRADECANOYLPHORBOL ACETATE;

ANIMALIA; MURINAE;

EID: 0028946520     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.2940120106     Document Type: Article

References (66)

1. Aspirin and the potential role of prostaglandins in colon cancer
2. Final report on the aspirin component of the ‘ongoing physicians’ health study
3. Aspirin use and reduced risk of colon cancer
4. A hypothesis: Nonsteroidal anti‐inflammatory drugs reduce the incidence of large‐bowel cancer
5. Colorectal cancer risk, chronic illnesses, operations, and medications: Case control results from the Melbourne colorectal cancer study
6. Effect of aspirin and non‐steroidal anti‐inflammatory drugs on colorectal adenomas: Case‐control study of subjects participating in the Nottingham faecal occult blood screening programme
7. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous poliposis
8. Sulindac for polyposis of the colon
9. Sulindac causes regression of rectal polyps in familial adenomatous polyposis
10. Indomethacin treatment of rats with dimethyl‐hydrazine‐induced intestinal tumors
11. Inhibition of initiation and promotion by N‐methylnitrosourea‐induced colon carcinogenesis in rats by non‐steroid anti‐inflammatory agent indomethacin
12. Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D,L‐α‐difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet
13. From the normal cell to cancer: The multistep process of experimental skin carcinogenesis
14. Activation of the mouse cellular Harvey‐ras gene in chemically induced benign skin papillomas
15. Growth stimulation and tumor promotion in skin
16. Correlation between sensitivity of tumor promotion and sustained epidermal hyperplasia of mice and rats treated with TPA
17. Genetic changes in skin tumor progression: Correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7
18. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors
19. Eicosanoids and multistage carcinogenesis in NMRI mouse skin: Role of prostaglandins E and F in conversion (first stage of tumor promotion) and promotion (second stage of tumor promotion)
20. Events associated with mouse skin tumor promotion with respect to arachidonic acid metabolism: A comparison between SENCAR and NMRI mice
21. Structural requirements for time‐dependent inhibition of prostaglandin biosynthesis by antiinflammatory drugs
22. The control of free arachidonic acid levels
23. Prostaglandin endoperoxide synthase: Structure and catalysis
24. Role of eicosanoids in mammalian skin epidermis
25. Mitogen‐inducible prostaglandin G/H synthase: A new target for nonsteroidal antiinflammatory drugs
26. Prostaglandin endoperoxide synthase: Regulation of enzyme expression
27. Expression of a mitogen‐responsive gene encoding prostaglandin synthase is regulated by mRNA splicing
28. TIS 10, a phorbol ester tumor promoter‐inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue
29. Structure of the mitogen‐inducible TIS 10 gene and demonstration that the TIS 10‐encoded protein is a functional prostaglandin G/H synthase
30. cDNA cloning and functional activity of a glucocorticoid‐regulated inflammatory cyclooxygenase
31. Human cyclooxygenase‐2 cDNA
32. Characterization and hormonal regulation of the promoter of the rat prostaglandin endoperoxide synthase 2 gene in granulosa cells
33. Expression of a mitogen‐inducible cyclooxygenase in brain neurons: Regulation by synaptic activity and glucocorticoids
34. 2
35. Serum and glucocorticoid regulation of gene transcription and expression of the prostaglandin H synthase‐1 and prostaglandin H synthase‐2 isozymes
36. Prostaglandin G/H synthase isoenzyme 2 expression in fibroblasts: Regulation by dexamethasone, mitogens, and oncogenes
37. Expression of the protein product of the prostaglandin synthase‐2/TIS 10 gene in mitogen‐stimulated Swiss 3T3 cells
38. Purification and characterization of a novel, distinct isoform of prostaglandin endoperoxide synthase induced by human chorionic gonadotropin in granulosa cells of rat preovulatory follicles
39. Hormonal regulation of messenger ribonucleic acid encoding a novel isoform of prostaglandin endoperoxide H synthase in rat preovulatory follicles
40. Characterization and hormonal regulation of the promoter of the rat prostaglandin endoperoxide synthase 2 gene in granulosa cells
41. The aspirin and heme‐binding sites of ovine and murine prostaglandin endoperoxide synthases
42. Properties of carcinogen altered mouse epidermal cells resistant to calcium‐induced terminal differentiation
43. Development of murine epidermal cell lines which contain an activated ras Ha oncogene and form papillomas in skin grafts on athymic nude mouse hosts
44. Phenotypic and cytogenetic characteristics of different stages during spontaneous transformation of mouse keratinocytes in vitro
45. Genetic changes in skin tumor progression: Correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7
46. Rapid extraction of arachidonic acid metabolites from biological samples using octadecylsilyl silica
47. Profiling assay for lipoxygenase products of linoleic and arachidonic acid by gas chromatography‐mass spectrometry
48. Cleavage of structural proteins during the assembly of the head and bacteriophage T4
49. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
50. Single‐step method of RNA isolation by acid guanidinium thiocyanate‐phenol‐chloroform extraction
51. Tumor‐specific over‐expression of a novel keratinocyte lipid‐binding protein
52. 2 release and enhanced cell proliferation induced by the phorbol ester TPA in a murine epidermal cell line
53. 2 by bradykinin and 4β‐phorbol 12‐myristate 13 acetate
54. Early prostaglandin E synthesis is an obligatory event in the induction of cell proliferation in mouse epidermis in vivo by the phorbol ester TPA
55. Prostaglandins, epidermal hyperplasia and skin tumor promotion
56. Tumor promoter‐inducible genes are differentially expressed in the developing mouse
57. Cloning of tetradecanoyl phorbol ester‐induced ‘primary response’ sequences and their expression in density‐arrested Swiss 3T3 cells and a TPA non‐proliferative variant
58. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor‐α and phorbol ester
59. Protein kinase C ζ and η in murine epidermis‐TPA induces down‐regulation of PKC η but not PKC ζ
60. Phorbol‐ester‐inducible genes contain a common cis element recognized by a TPA‐modulated trans‐acting factor
61. Prostaglandin endoperoxide synthase gene structure: Identification of the transcriptional start site and 5′ flanking regulatory sequences
62. Expression of simple epithelial keratins in mouse epidermal keratinocytes harbouring Harvey‐ras gene alterations
63. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non‐steroidal anti‐inflammatory drugs
64. NS‐398, a new anti‐inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX‐2) activity in vitro
65. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase
66. Isolation, characterization and in vitro cultivation of subfractions of neonatal mouse keratinocytes: Effects of phorbol esters